US Food and Drug Administration
China approves homegrown oral antiviral for treating COVID-19
The Chinese company producing Azvudone claimed that 40% of COVID-19 patients administered the drug for more than a week during the third phase of the clinical trial showed improvements when it came to symptoms
- Google employees lead sit-ins protesting company’s complicity in genocide
- Israeli tourists attack vigil in Cusco in support of Palestine
- During Red April, Brazil’s MST restates the importance of agrarian reform
- German authorities’ crackdown on Palestine Conference sparks widespread outrage
- As elections approach, India’s farmers count government’s broken promises
